Neurosteer
Remote Brain Activity Monitoring and Assessment Platform
Startup Seed Health Tech & Life Sciences Est. 2015
Total Raised
$2.56M
Seed
Last Round
$58.4K
2 rounds
Investors
1
1 public
Team
5
11-50 employees
Confidence
100/100
News
4
articles
Patents
1
About
Neurosteer has developed a solution designed for early detection and more effective treatment of a variety of neurological disorders. Its platform consists of a medical-grade wearable device and a cloud-based system that provide real-time monitoring and assessment of brain activity. The companys current focus is on delivering objective biomarkers to identify the early onset of Parkinsons disease, Alzheimers disease, dementia, and epilepsy. Neurosteer uses an adhesive forehead strip connected to a pocket-sized device that wirelessly transmits sensor data to the cloud for proprietary signal processing. Advanced algorithms then decompose the single EEG channel into over 100 individual components for real-time analysis and display on a web-based dashboard. The results are more affordable screening, continuous patient monitoring, and optimized neurostimulation and drug selection, leading to improved neurological treatment and clinical trial outcomes.
Classification
Sector
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical MonitorsDiagnostics Devices
Core Technology
Artificial IntelligenceMachine LearningData StorageCloudSemiconductors & ElectronicsWearablesSensing
Target Customer
Healthcare & Life SciencesHealthcarePatientsProvidersLife SciencesPharmaceuticals
Business Model
B2CB2B
Tags
diagnosticsneurologymonitoringdigital-healthcaresignal-processingalzheimers-diseasesensorshospitalshealthcare-providersemotions-analyticsepilepsydata-analyticsbig-datapatientsnon-invasiveartificial-intelligencewearableneurosciencemachine-learningmedical-devicescloud-basedpharma-companiesearly-detectionbiomarkerswellnesshome-carebrain-disorderremote-monitoring
Funding & Events
Sep 2015
Seed $2.5M
Arkady Volozh
Jun 2018
Non-equity $58.4K
EU Horizon 2020
News (4)
Mar 10, 2020 · blogs.timesofisrael.com
growth-positive
Neurosteer pursues wearable device to detect Alzheimer's
CustomersInvestment
Apr 10, 2019 · www.israel21c.org
growth-positive
New monitoring tool could revolutionize brain treatment
CustomersInvestment
Sep 14, 2016 · medium.com
growth-positive
Cracking the Code on Mobile Brain Monitoring -Nathan Intrator, Neurosteer-Full
Expand
Nov 2, 2015 · www.healtheuropa.eu
Neurosteer: introducing a novel brain activity monitor
Details
Product Stage
Clinical Trial
Employees
11-50
Exact Count
12
District
Center District
Founded
2015
Registrar
515297265
Crunchbase
neurosteer-ltd
Locations
Arieh Shenkar St 1, Herzliya, Israel
375 South End Avenue, New York, NY, USA
Links
Website
LinkedIn
Twitter
Facebook
Admin
Last Update
Sep 7, 2024
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets
Team (5)
Prof. Nathan Intrator
Founder
Founder
Gil Shoshan
Algorithm Engineer
Lior Molcho
Clinical Trials Manager
Neta Maimon
Director Musical Cognition
Danny Gross
Senior Software Architect
Internal
Created by
Noy Barak (bn.barak.noy@gmail.com)
Created
2015-07-17T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wain@gmail.com)